Our Department Mission....Delivering Excellence and Trust in Pharmaceutical Care through a Culture of Precision.

Restricted: ID consult required

Search results for:

DALFOPRISTIN-QUINUPRISTIN - RESTRICTED

DALFOPRISTIN-QUINUPRISTIN - RESTRICTED
Drug Name Form Strength Non-Formulary Notes
SYNERCID POWDER FOR INJECTION 350 mg-150 mg  

View Other Therapeutic Options: Antibacterials, Miscellaneous, Streptogramins: 081228, 08122832

Comments:

Nonformulary - Recommend Vancomycin IV per pharmacy dosing.  An ID consult must be obtained and an order received from an ID provider prior to dispensing quinupristin/dalfopristin (Synercid).


Last updated: Aug. 16, 2017


This site is intended for the staff of Genesis Health System.
While others may view accessible pages, Genesis Health System makes no warranty, express or implied,
as to the use of this information outside of Genesis Health System.